Insect Control: Biological and Synthetic Agents - Index of
Insect Control: Biological and Synthetic Agents - Index of
Insect Control: Biological and Synthetic Agents - Index of
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
generated in control neonates infected with wildtype<br />
RoMNPV. The ST50s <strong>of</strong> Ro6.9LqhIT2 infected<br />
neonate H. zea <strong>and</strong> H. virescens were also significantly<br />
lower than control neonates infected with a<br />
recombinant RoMNPV expressing AaIT under the<br />
p6.9 promoter.<br />
Chejanovsky et al. (1995) have generated a<br />
recombinant AcMNPV (AcLa22) that expresses the<br />
L. quinquestriatus hebraeus derived alpha toxin,<br />
LqhaIT (Eitan et al., 1990). The LT50 <strong>of</strong> AcLa22<br />
was roughly 35% faster (78 versus 120 h) than that<br />
<strong>of</strong> the wild-type AcMNPV in larvae <strong>of</strong> H. armigera.<br />
Since the LqhaIT toxin binds at a different site on<br />
the insect sodium channel from that <strong>of</strong> the excitatory<br />
toxins (Zlotkin et al., 1978; Cestele <strong>and</strong> Catterall,<br />
2000), Chejanovsky et al. (1995) suggested that a<br />
baculovirus expressing both alpha <strong>and</strong> excitatory<br />
toxins may yield a synergistic interaction between<br />
the toxins. However, they cautioned that LqhaIT<br />
toxin lacks absolute selectivity for insects (Eitan<br />
et al., 1990); thus, a recombinant baculovirus<br />
expressing LqhaIT is not appropriate as a biological<br />
pesticide. The LqhaIT toxin, however, should be an<br />
effective tool to study the targeting <strong>of</strong> different types<br />
<strong>of</strong> toxins on the voltage gated sodium channel. The<br />
effectiveness <strong>of</strong> the use <strong>of</strong> multiple synergistic toxins<br />
is discussed below. Other examples <strong>of</strong> the expression<br />
<strong>of</strong> insect selective toxins from L. quinquestriatus<br />
hebraeus using alternative promoters, signal<br />
sequences for secretion, viral vectors, <strong>and</strong>/or insertion<br />
<strong>of</strong> the toxin gene at the egt gene locus are given<br />
later in this chapter.<br />
10.3.2. Mite Toxins<br />
The insect-predatory straw itch mite Pyemotes tritici<br />
encodes an insect paralytic neurotoxin TxP-I<br />
that induces rapid, muscle contracting paralysis in<br />
larvae <strong>of</strong> the greater wax moth G. mellonella<br />
(Tomalski et al., 1988, 1989). TxP-I is encoded by<br />
the tox34 gene as a precursor protein <strong>of</strong> 291 amino<br />
acid residues. The mature protein is secreted from<br />
the insect cell following cleavage <strong>of</strong> a 39 amino acid<br />
long signal sequence for secretion (Tomalski <strong>and</strong><br />
Miller, 1991). The mode <strong>of</strong> action <strong>of</strong> TxP-I is unknown,<br />
however, it is highly toxic (even at a dose <strong>of</strong><br />
500 mgkg 1 ) to lepidopteran larvae but not toxic<br />
to mice at a dose <strong>of</strong> 50 mg kg 1 . A recombinant,<br />
occlusion-negative AcMNPV (vEV-Tox34) expressing<br />
the tox34 gene under a modified polyhedrin<br />
promoter (PLSXIV; Ooi et al., 1989) was shown<br />
to paralyze or kill fifth instar larvae <strong>of</strong> T. ni by<br />
2 days post injection with 400 000 pfu <strong>of</strong> BV. In<br />
contrast, control larvae injected with BV <strong>of</strong> wildtype<br />
AcMNPV never showed symptoms <strong>of</strong> paralysis<br />
(Tomalski <strong>and</strong> Miller, 1991). Tomalski <strong>and</strong> Miller<br />
10: Genetically Modified Baculoviruses for Pest <strong>Insect</strong> <strong>Control</strong> 345<br />
(1991, 1992) have constructed two other occlusionnegative<br />
AcMNPVs that express the tox34 gene<br />
under early (vETL-Tox34) or hybrid late/very late<br />
(vCappolh-Tox34) gene promoters as well as an<br />
occlusion-positive AcMNPV (vSp-Tox34) expressing<br />
tox34 under a different hybrid late/very late<br />
promoter. The activities <strong>of</strong> these constructs will<br />
be discussed later in this chapter. Lu et al. (1996)<br />
have constructed an occlusion-positive AcMNPV<br />
(vp6.9tox34) that utilizes the late p6.9 promoter<br />
to drive expression <strong>of</strong> tox34. Use <strong>of</strong> this late promoter<br />
resulted in earlier, by at least 24 h, <strong>and</strong> higher<br />
level <strong>of</strong> TxP-I expression in comparison to TxP-I<br />
expression under a very late promoter. As discussed<br />
above, the p6.9 gene promoter is not an<br />
early promoter, but is activated earlier <strong>and</strong> can<br />
drive higher levels <strong>of</strong> expression than very late promoters<br />
in tissue culture (Hill-Perkins <strong>and</strong> Possee,<br />
1990; Bonning et al., 1994). In time-mortality<br />
bioassays (at an LC95 dose), the median time to<br />
effect (ET 50) <strong>of</strong> vp6.9tox34 in neonate larvae <strong>of</strong><br />
S. frugiperda <strong>and</strong> T. ni was reduced by approximately<br />
56% (44.7 versus 101.3 h) <strong>and</strong> 58% (41.7<br />
versus 99.0 h), respectively, in comparison to wildtype<br />
AcMNPV. In neonate S. frugiperda <strong>and</strong> T. ni,<br />
the earlier <strong>and</strong> higher level <strong>of</strong> TxP-I expression<br />
under the late promoter resulted in a 20–30% faster<br />
induction <strong>of</strong> effective paralysis or death in comparison<br />
to TxP-I expression under the very late gene<br />
promoter.<br />
Burden et al. (2000) have constructed a slightly<br />
different TxP-I encoding gene (tox34.4) by RT-PCR<br />
<strong>of</strong> mRNAs purified from total RNA extracted from<br />
P. tritici using primers designed to amplify the tox34<br />
open reading <strong>of</strong> Tomalski <strong>and</strong> Miller (1991). A<br />
recombinant AcMNPV (AcTOX34.4) expressing<br />
TxP-I under the p10 promoter has been generated.<br />
The LD50s <strong>of</strong> AcTOX34.4 were not significantly<br />
different than those <strong>of</strong> the wild-type AcMNPV in<br />
dose-mortality bioassays <strong>of</strong> second (9.3 polyhedra<br />
per larva) <strong>and</strong> fourth (13.1 polyhedra per larva)<br />
instar larvae <strong>of</strong> T. ni. In time-mortality bioassays,<br />
second <strong>and</strong> fourth instar larvae <strong>of</strong> T. ni infected with<br />
AcTOX34.4 showed a 50–60% reduction (depending<br />
on virus dose <strong>and</strong> instar) in the mean time to<br />
death in comparison to control larvae infected with<br />
wild-type AcMNPV. There was also a dramatic<br />
reduction in the yield <strong>of</strong> progeny virus (number <strong>of</strong><br />
polyhedra per mg <strong>of</strong> cadaver) at the time <strong>of</strong> death.<br />
Second <strong>and</strong> fourth instar larvae <strong>of</strong> T. ni that were<br />
infected with AcTOX34.4 produced roughly 85%<br />
<strong>and</strong> 95% lower yields <strong>of</strong> polyhedra per unit<br />
weight, respectively, in comparison to control larvae<br />
infected with AcMNPV. On the basis <strong>of</strong> pathogen–<br />
host model systems that describe how insect viruses